AndreaBozzo/ceres-open-data-index huggingface dataset:
Monthly Cumulative Number and Percent of Persons Who Received ≥1 Influenza Vaccination Doses, by Flu Season, Age Group, and Jurisdiction

Monthly Cumulative Number and Percent of Persons Who Received ≥1 Influenza Vaccination Doses, by Flu Season, Age Group, and Jurisdiction

• Influenza vaccination coverage for children and adults is assessed through U.S. jurisdictions’ Immunization Information Systems (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group. More information about the IIS can be found at https://www.cdc.gov/vaccines/programs/iis/about.html.

• Influenza vaccination coverage estimate numerators include the number of people receiving at least one dose of influenza vaccine in a given flu season, based on information that state, territorial, and local public health agencies report to CDC. Some jurisdictions’ data may include data submitted by tribes. Estimates include persons who are deceased but received a vaccination during the current season. People receiving doses are attributed to the jurisdiction in which the person resides unless noted otherwise. Quality and completeness of data may vary across jurisdictions. Influenza vaccination coverage denominators are obtained from 2020 U.S. Census Bureau population estimates.

• Monthly estimates shown are cumulative, reflecting all persons vaccinated from July through a given month of that flu season. Cumulative estimates include any historical data reported since the previous submission. National estimates are not presented since not all U.S. jurisdictions are currently reporting their IIS data to CDC. Jurisdictions reporting data to CDC include U.S. states, some localities, and territories.

• Because IIS data contain all vaccinations administered within a jurisdiction rather than a sample, standard errors were not calculated and statistical testing for differences in estimates across years were not performed.

• Laws and policies regarding the submission of vaccination data to an IIS vary by state, which may impact the completeness of vaccination coverage reflected for a jurisdiction. More information on laws and policies are found at https://www.cdc.gov/vaccines/programs/iis/policy-legislation.html.

• Coverage estimates based on IIS data are expected to differ from National Immunization Survey (NIS) estimates for children (https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-coverage-race.html)
and adults (https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-adult-coverage.html) because NIS estimates are based on a sample that may not be representative after survey weighting and vaccination status is determined by survey respondent rather than vaccine records or administrations, and quality and completeness of IIS data may vary across jurisdictions. In general, NIS estimates tend to overestimate coverage due to overreporting and IIS estimates may underestimate coverage due to incompleteness of data in certain jurisdictions.
Compound 529236: Propanamide, N-DMTBS

Chemical compound data from PubChem database. IUPAC Name: N-[tert-butyl(dimethyl)silyl]propanamide. Molecular Formula: C9H21NOSi. Molecular Weight: 187.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527684: Butanoic acid, 3-chloro, 1,1-dimethylpropyl ester

Chemical compound data from PubChem database. IUPAC Name: 2-methylbutan-2-yl 3-chlorobutanoate. Molecular Formula: C9H17ClO2. Molecular Weight: 192.68. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527379: 21,27-Dimethylnonacosanenitrile

Chemical compound data from PubChem database. IUPAC Name: 21,27-dimethylnonacosanenitrile. Molecular Formula: C31H61N. Molecular Weight: 447.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2010 State Profile — Missouri

This state profile includes data from facilities in Missouri that reported to N-SSATS for the survey reference date March 31, 2010. Data were collected on the location, characteristics, services offered, and number of clients in treatment at alcohol and drug abuse treatment facilities (both public and private) in Missouri. In Missouri, 264 substance abuse treatment facilities were included in the 2010 N-SSATS, reporting that there were 19,766 clients in substance abuse treatment on March 31, 2010. The survey response rate in Missouri was 95.1%.
Compound 525850: N,N-Dimethyl-2-phenyl-N'-(3-methoxyphenyl)-acetamidine

Chemical compound data from PubChem database. IUPAC Name: N'-(3-methoxyphenyl)-N,N-dimethyl-2-phenylethanimidamide. Molecular Formula: C17H20N2O. Molecular Weight: 268.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Health Insurance Exchanges Annual Effectuated Enrollment

The Health Insurance Exchanges Annual Effectuated Enrollment data provide select metrics on annual average effectuated enrollment across the Federally Facilitated Exchange (FFE) and State Based Exchanges on the Federal Platform (SBE-FPs), which both use the federal enrollment platform (HealthCare.gov), as well as State Based Exchanges (SBEs) that operate their own eligibility and enrollment platforms.

These metrics include average effectuated enrollment, the average  number of consumers with Advanced Premium Tax Credit (APTC) subsidies, the average number of consumers with Cost Sharing Reduction (CSR) subsidies, and the average APTC subsidy amount for  consumers receiving APTC, at the state level.
Compound 525374: 2,4-Dimethyl-3,5-dithiahexane

Chemical compound data from PubChem database. IUPAC Name: 2-(1-methylsulfanylethylsulfanyl)propane. Molecular Formula: C6H14S2. Molecular Weight: 150.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525783: 4-Butyl-2-methyloxazole

Chemical compound data from PubChem database. IUPAC Name: 4-butyl-2-methyl-1,3-oxazole. Molecular Formula: C8H13NO. Molecular Weight: 139.19. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525864: N,N-Dimethyl-2-phenyl-N'-hexyl-acetamidine

Chemical compound data from PubChem database. IUPAC Name: N'-hexyl-N,N-dimethyl-2-phenylethanimidamide. Molecular Formula: C16H26N2. Molecular Weight: 246.39. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E40062-T1: [Translated] ELECTRIC HEATING ELEMENT.

An electrical heating element comprising a resistive element consisting of granular boron carbide packed in a quartz tube embedded in a piece of copper. A first power lead is electrically connected to the boron carbide at one end of the quartz tube. This first power lead passes through and is electrically insulated from the piece of copper. The second power lead is electrically connected to the boron carbide at the other end of the quartz tube, either directly or via the piece of copper. In use, connection of the first and second leads to an electrical power source causes the resistive element to generate heat in a very fast manner and to trandmit this heat to the piece of copper.
Compound 526903: 2-(2-Pentoxyethoxy)ethyl trifluoroacetate

Chemical compound data from PubChem database. IUPAC Name: 2-(2-pentoxyethoxy)ethyl 2,2,2-trifluoroacetate. Molecular Formula: C11H19F3O4. Molecular Weight: 272.26. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526508: 2-Isothiocyanato-2-methylpropionic acid ethyl ester

Chemical compound data from PubChem database. IUPAC Name: ethyl 2-isothiocyanato-2-methylpropanoate. Molecular Formula: C7H11NO2S. Molecular Weight: 173.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Rates of TBI-related Emergency Department Visits, Hospitalizations, and Deaths by Sex - United States, 2001 – 2010

Overall rates of TBI climbed slowly from 2001 through 2007, then spiked sharply in 2008 and continued to climb through 2010.  The increase in TBI rates in 2008 was much sharper for men (nearly 40% increase) than for women (20% increase).  In 2007, overall rates of TBI were 26% higher in men compared to women.  In 2008, that gap began to widen, reaching 61% in 2009 before narrowing to 29% in 2010.  Rates of overall TBI are largely driven by rates of TBI-related ED visits.
Developmental Victimization Survey (DVS), 2002-2003

The Developmental Victimization Survey (DVS), was designed to obtain one-year incidence estimates of a comprehensive range of childhood victimizations across gender, race, and developmental stage.  Conducted between December 2002, and February 2003, it assessed the experiences of a nationally representative sample of children age 2-17 living in the contiguous United States.The sample selection procedures were based on a list-assisted random digit dial (RDD) telephone survey design. A short interview was conducted with an adult caregiver (usually a parent) to obtain family demographic information.  One child was randomly selected from all eligible children living in a household by selecting the child with the most recent birthday.  If the selected child was 10-17 years old, the main telephone interview was conducted with the child.  If the selected child was 2-9 years old, the interview was conducted with the caregiver who “is most familiar with the child’s daily routine and experiences.”  Interviews were completed with 79.5% of the eligible persons contacted.  All procedures were authorized by the Institutional Review Board of the University of New Hampshire.This survey utilized the Juvenile Victimization Questionnaire (JVQ), a recently constructed inventory of childhood victimization. The JVQ obtains reports on 34 forms of offenses against youth that cover five general areas of concern: Conventional Crime, Child Maltreatment, Peer and Sibling Victimization, Sexual Assault, and Witnessing and Indirect Victimization.  Follow-up questions for each screener item gathered additional information, including perpetrator characteristics, the use of a weapon, whether injury resulted, and whether the event occurred in conjunction with another screener.  The final sample represented 2,030 children age 2-17 living in the contiguous United States.  Half (50%) of the sample is male; 51% are 2-9 year olds, while 49% are age 10-17.  Almost 10% of the sample reported a household income of under $20,000, while about 34% had annual incomes between $20,000 and $50,000.  The survey sample is 76% White (non-Hispanic), 11% Black (non-Hispanic), 9% Hispanic (any race) and 3.5% from other races including American Indian and Asian.

Investigators: Heather Turner
University of New Hampshire Durham, NH

David Finkelhor, Ph.D.
University of New Hampshire Durham, NH
Patent AT-E399965-T1: [Translated] HEAT STORAGE AND USE OF THE HEAT STORAGE IN A HEATING SYSTEM WITH SOLAR SYSTEM AND HEAT PUMP

The invention relates to a heat accumulator having at least one first volume and one second volume. Said volumes are separate, can be respectively filled with, or passed through, by a medium, and are in, or can be brought into, thermal contact. The invention is characterised in that another volume that can be filled with a fluid and emptied, a so-called switchable volume, is provided between at least the first and second volumes, said switchable volume being in thermal contact with the media of the first and second volumes.
Chlorhexidine gluconate 4%

Chlorhexidine Gluconate is an antiseptic skin cleanser and surgical scrub available over-the-counter in a 4% topical solution. It's used to reduce bacteria on the skin before surgery or medical procedures, helping prevent infections. Common brands include Antiseptic Skin Cleanser and Betasept, manufactured by companies like Cardinal Health. This information was generated using AI and is provided for informational and research purposes only.
Compound 529449: 6,10,10-Trimethyl-11-oxatricyclo[7.2.1.01,6]dodec-2-ene

Chemical compound data from PubChem database. IUPAC Name: 6,10,10-trimethyl-11-oxatricyclo[7.2.1.01,6]dodec-2-ene. Molecular Formula: C14H22O. Molecular Weight: 206.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Eptifibatide

Eptifibatide is an injectable medication that prevents blood clots by inhibiting platelet aggregation. It's administered intravenously and used to treat acute coronary syndromes, reducing the risk of heart attacks. Available in strengths like 2 mg/mL and 75 mg/100 mL from Slate Run Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only.
Miscellaneous Tables (Standard Errors and P Values) - 6.1 to 6.107

These detailed tables present the standard errors for the totals and prevalence estimates of the number of days and types of substance use, poly-drug use, nicotine dependence, substance dependence by age of first use, source of substances, social context of substance use, and drunk/drugged driving from the 2010 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs, marijuana, cocaine, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, and sedatives, and alcohol. Standard errors are provided for totals and prevalence estimates of lifetime, past year, and past month use by age group, gender, race/ethnicity, education level, employment status, geographic area, pregnancy status, college enrollment status, and probation/parole status. Comparisons are made between 2010 and 2009.
Housing’s Critical Connection to Child Welfare — Part 2

This Child Welfare Information Gateway Podcast is available on Apple Podcasts
  
  

, GooglePlay
  
  

, Spotify
  
  

, Stitcher
  
  

, SoundCloud
  
  

, and the Child Welfare Information Gateway
  
  

 website. Subscribe to receive new episodes as they are released.

Metadata-only record linking to the original dataset. Open original dataset below.
SHIP Teen Birth Rate 2010-2021

This is historical data. The update frequency has been set to "Static Data" and is here for historic value. Updated on 8/14/2024

Teen Birth Rate - This indicator shows the rate of births to teens ages 15-19 years (per 1,000 population). Teen pregnancy is linked to a host of social problems such as poverty, lack of overall child well-being, out-of-wedlock births, lack of responsible fatherhood, health issues, school failure, child abuse and neglect and at-risk behaviors. <a href ="https://health.maryland.gov/pophealth/Documents/SHIP/SHIP%20Lite%20Data%20Details/Teen%20Birth%20Rate.pdf" > Link to Data Details </a>
'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations

Cystic fibrosis is a genetic disease that is associated with abnormal sweat electrolytes, sino-pulmonary disease, exocrine pancreatic insufficiency, and male infertility. Insights into genotype/phenotype relations have recently been gained in this disorder. The strongest relationship exists between 'severe' mutations in the gene that encodes the cystic fibrosis transmembrane regulator (CFTR) and pancreatic insufficiency. The relationship between 'mild' mutations, associated with residual CFTR function, and expression of disease is less precise. Atypical 'mild' mutations in the CFTR gene have been linked to late-onset pulmonary disease, congenital bilateral absence of the vas deferens, and idiopathic pancreatitis. Less commonly, sinusitis, allergic bronchopulmonary aspergillosis, and possibly even asthma may also be associated with mutations in the CFTR gene, but those syndromes predominantly reflect non-CFTR gene modifiers and environmental influences.
NNDSS - Table II. Lyme disease to Meningococcal

NNDSS - Table II. Lyme disease to Meningococcal - 2016. In this Table, provisional* cases of selected† notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories.

Note:
These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. 

Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. 

Footnotes:
C.N.M.I.: Commonwealth of Northern Mariana Islands. 
U: Unavailable.    -: No reported cases.    N: Not reportable.    NN: Not Nationally Notifiable.  NP:  Nationally notifiable but not published.    Cum: Cumulative year-to-date counts.    Med: Median.    Max: Maximum.

* Case counts for reporting year 2016 are provisional and subject to change.   For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly. 
† Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions.
§ Data for meningococcal disease, invasive caused by serogroups ACWY; serogroup B; other serogroup; and unknown serogroup are available in Table I.
Patent AT-E400593-T1: [Translated] POLYMERIZATION CURABLE COMPOSITION

A polymerization curable composition comprising a specific polyfunctional polymerizable monomer having a hard molecular structure with an L-scale Rockwell hardness of its homopolymer of 60 or more, a specific polyfunctional polymerizable monomer and a photochromic compound, a photochromic lens substrate composed of a cured product of the polymerization curable composition, and a lens comprising the photochromic lens substrate. <??>The substrate and lens show excellent photochromic properties such as high color development density and high fading rate, and the cured product has excellent substrate properties such as hardness, heat resistance and impact resistance as well as strength (toughness) that allows for its use in rimless spectacles.
2015 CMHS Uniform Reporting System (URS) Table for Virginia

2015 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Virginia. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 526221: 1,2,3,4,6-Pentabromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,2,3,4,6-pentabromodibenzofuran. Molecular Formula: C12H3Br5O. Molecular Weight: 562.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528767: Tricyclo[5.2.1.0(2.6)]deca-3,8-diene, 3,8-dimethyl

Chemical compound data from PubChem database. IUPAC Name: 3,8-dimethyltricyclo[5.2.1.02,6]deca-3,8-diene. Molecular Formula: C12H16. Molecular Weight: 160.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525385: 2,5-Dithiaheptane

Chemical compound data from PubChem database. IUPAC Name: 1-ethylsulfanyl-2-methylsulfanylethane. Molecular Formula: C5H12S2. Molecular Weight: 136.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
A Comparative Study of the Use and Effectiveness of Different Risk Assessment Models in CPS Decision Making Processes

Three risk assessment models will be evaluated, using data collected on cases from three sites.  In addition to the primary study of objectives of assessing reliability and validity of existing risk assessment models, the researchers will use the data collected to develop the optimal risk instrument for each site and for all sites combined.  Investigators will use statistical analyses to determine the influence of various agency and worker factors on outcomes. Cultural differences will be given special emphasis.  Sites will be chosen to ensure numbers sufficient to analyze system model performance with African Americans, Hispanics, and Caucasians.  Researchers will make an effort to obtain a significant American Indian population.

Investigators: Baird, Christopher
Compound 528008: 2-Propynyl 4-nitrobenzoate

Chemical compound data from PubChem database. IUPAC Name: prop-2-ynyl 4-nitrobenzoate. Molecular Formula: C10H7NO4. Molecular Weight: 205.17. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Localities for 2010A

Payment files reflect a change in the conversion factor as a result of the Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, which President Obama signed into law on June 25, 2010. This legislation provides for a 2.2 percent update to the 2010 Medicare Physician Fee Schedule (MPFS), effective for dates of service June 1, 2010, through November 30, 2010. For 2010A: Payment files reflect changes as a result of practice expense (PE) and malpractice (MP) relative value unit (RVU) corrections and provisions of the Patient Protection and Affordable Care Act (the Affordable Care Act), as modified by the Health Care and Education Reconciliation Act of 2010, which President Obama signed into law on March 23, 2010, and March 30, 2010, respectively.
Compound 526357: 3,8-Dibromo-1,6-dichloro-dibenzo-p-dioxin

Chemical compound data from PubChem database. IUPAC Name: 3,8-dibromo-1,6-dichlorodibenzo-p-dioxin. Molecular Formula: C12H4Br2Cl2O2. Molecular Weight: 410.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.